© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
The history of imidazole derivatives like 2-Methyl-4,5-nitroimidazole traces back to a period when scientists searched for compounds that could disrupt microbial growth or enhance selectivity in synthesis. Chemists in the mid-20th century knew that imidazole rings cropped up not only in biological molecules but also in many medical treatments. Once nitration methods improved, folks found ways to place functional groups like methyl and nitro onto those rings. The work in this area opened doors for medicinal designers and chemists looking beyond basic structures; more functionalized imidazoles meant more possibilities in fields from pharmaceuticals to materials science. I remember running across research papers outlining these advances and noticing that a lot of progress stemmed from persistent tweaks to preparation methods and a willingness to try unconventional reagents. Researchers kept the focus on building a toolbox, not just hunting for blockbuster drugs, so a lot of knowledge scattered through patent archives and forgotten journals, waiting for new applications.
2-Methyl-4,5-nitroimidazole doesn’t carry the household recognition of paracetamol or penicillin, yet its combination of a methyl group at the second position and two nitro groups along the aromatic core gives it a pretty distinct chemical fingerprint. Chemists value this scaffold because nitro-bearing heterocycles participate in a variety of biological assays and serve as intermediates for more complex molecules. I’ve talked to colleagues who use this compound as a starting point for making derivatives used in diagnostics or as potential enzyme inhibitors. The diversity in its application underscores how one small change in ring substitution can profoundly alter chemical behavior and open new research frontiers.
If you sit down with a sample of 2-Methyl-4,5-nitroimidazole, you’ll likely encounter a pale to yellowish crystalline solid, sometimes with a slight odor. The nitro groups contribute to a relatively high melting point and a certain rigidity in molecular structure, making it behave differently from simpler imidazoles. Its limited solubility in water but improved solubility in organic solvents like DMSO or ethanol gives synthetic chemists options when choosing how to incorporate it into reactions. Its electron-withdrawing nitro groups can intensify both its oxidative sensitivity and its versatility as a substrate in various reduction or nucleophilic substitution reactions.
Accurate labeling becomes crucial, especially with nitroimidazoles, considering their biological activity and variable toxicity. Quality control labs run purity assays, and the accepted analytical methods—thin-layer chromatography, NMR, and elemental analysis—help rule out unreacted starting materials or isomeric impurities. Proper labeling points out not just the chemical name and concentration but also hazard warnings sourced from standard toxicity research. Labels make it clear how to store the compound, usually in cool and dry conditions, and underscore the risks of inhalation or skin contact common to nitro-functionalized aromatics. Documentation reflecting the latest hazard data makes a big difference when a researcher prepares to handle these chemicals.
Standard routes to 2-Methyl-4,5-nitroimidazole draw from the classical chemistry of imidazole rings. One practical method starts with methyl-substituted imidazole, followed by direct nitration under carefully controlled acidic conditions. Too much heat or prolonged reaction time sometimes causes over-oxidation or decomposition, so experienced syntheses keep conditions mild and quench the reaction as soon as the desired product forms. Those nitro groups demand attention; letting the mixture sit at high temperature for too long worsens yields. In some labs, microwave heating or alternative solvents help to streamline the workup, but traditionalists still swear by ice baths and slow, cold addition of nitrating agents to avoid runaway exotherms.
Once synthesized, 2-Methyl-4,5-nitroimidazole opens up opportunities for further tinkering. The nitro groups provide sites for reduction to amines, substitutions with nucleophiles, and the base methyl group can direct regioselectivity in subsequent aromatic reactions. Chemists can transform it into amino-derivatives for use as ligands, or into azoles that display different pharmacological activity. Some teams use it to build up more complex heterocyclic frameworks, essentially turning a basic template into an individualized scaffold that interacts with enzymes or metallic catalysts in unique ways. Although it contains electron-withdrawing groups, skilled synthetic chemists manipulate the molecule using both classical and modern approaches—hydrogenation, SNAr reactions, and transition-metal catalysis among them.
Those familiar with chemical catalogs might have come across 2-Methyl-4,5-nitroimidazole under various names. Some know it simply as “2-Methyl-4,5-dinitroimidazole,” which points to a common confusion between mono- and dinitro derivatives during ordering. Chemical Abstracts Service (CAS) registry lists secure easier tracking, but commercial suppliers sometimes give proprietary product codes, adding to confusion in multi-vendor procurement scenarios. The multitude of synonyms and misspellings sometimes slows collaboration when cross-referencing safety data sheets or searching academic databases, especially when translations add more ambiguity.
Handling nitroimidazoles always calls for personal vigilance, partly due to the toxicity profile and the reactivity of nitroaromatic compounds. Users wear gloves and work in well-ventilated fume hoods, and disposal aligns with regulatory guidance to avoid environmental contamination. Nitroimidazoles raise red flags for potential mutagenic or teratogenic effects—outcomes underscored by decades of animal studies and flagged by governing agencies. Researchers document any spills or exposures using standard lab notebooks and incident reports, both as a learning tool and a compliance measure. Those following the operational standards help foster safe lab culture, minimize unnecessary risk, and model best practices for students and junior staff who need real-life examples to guide their own lab habits.
Chemists and pharmacologists reach for 2-Methyl-4,5-nitroimidazole for its role in advanced synthesis and biological screening. In medicinal chemistry, imidazole derivatives pop up as building blocks in anti-parasitic agents, enzyme inhibitors, or radiolabeled probes for imaging studies. Not all analogues reach market or clinical trial, but their structural similarity to biologically active compounds in metronidazole or benznidazole ensures their place in preclinical research benches. For analytical chemists, these molecules make appearances as internal standards or as spiked controls to validate quantitative assays. Over time, synthetic clusters around nitroimidazole cores serve as jumping-off points for high-throughput screening campaigns, where new properties can emerge almost by accident.
I’ve watched people spend years exploring what happens when you slightly adjust positions or substituents on the imidazole ring. Some invest in new catalytic systems to make synthesis faster or less wasteful. Others pursue structure-activity relationship studies, trying to understand why one variant binds an enzyme pocket a certain way or why toxicity suddenly spikes at high concentrations. Cross-disciplinary teams sometimes discover a forgotten compound like 2-Methyl-4,5-nitroimidazole fits into a niche diagnostic platform or a polymer matrix, breathing new life into seemingly well-explored molecules. Big grants get written for screening every possible analog, but many breakthroughs come from teams working through tedious analytical work and small-scale bioassays.
The dark side of nitroimidazole research emerges in toxicity studies, which repeatedly flag genetic and cellular risks. Laboratory animals exposed to high doses show disruptions at the chromosomal level. Many nitroazoles share this pattern, so researchers rely on protective equipment and strict protocols. Work in this field does not just serve as a warning; the lessons from mammalian cell studies guide safer compound design. Modern efforts lean on newer tissue models and thick data analysis, seeking out thresholds where compounds can serve medicinal goals without causing lasting cellular damage. There’s a sense of responsibility when you work with these chemicals—balancing innovation against the weight of what’s already known about long-term exposure effects.
It’s not easy to predict which analogs might jump from dusty shelf to trending topic in research circles, but trends push chemists to look for both utility and safety. Advances in computational modeling and high-throughput screening might shine new light on 2-Methyl-4,5-nitroimidazole as a useful intermediate or selective probe. Eco-friendlier syntheses draw more attention, especially as sustainability demands reshape research funding and regulatory landscapes. Mediators and catalysts designed with greener chemistry in mind could make production safer both for workers and the climate. When chemists blend experience with new technology—drawing from lessons learned over decades—molecules like this one could end up in unexpected applications or act as stepping stones for the next generation of bioactive heterocycles.
Walk into any university chemistry lab or pharmaceutical research center, and researchers in white coats pore over flasks filled with strange powders and fluids. Among these, 2-Methyl-4,5-nitroimidazole doesn’t attract headlines, but its presence signals cutting-edge work. This compound belongs to the nitroimidazole family, which pulls plenty of weight in fighting infections and as intermediates in designing drugs. My old professor used to say, “Some molecules keep the lights on—these kinds keep the sick living.”
Most folks probably haven’t heard of 2-Methyl-4,5-nitroimidazole, but the nitroimidazole group has a record in tackling serious bacterial and protozoal infections. Metronidazole, a cousin with a similar backbone, stands as a core treatment for ailments like giardiasis and bacterial vaginosis. 2-Methyl-4,5-nitroimidazole itself plays a key part upstream, acting as a chemical building block when drug developers want to create medicines that target infections stubborn to older treatments.
Workshops and research centers, more than clinics, depend on 2-Methyl-4,5-nitroimidazole. This compound helps chemists build structures with the right balance of stability and reactivity. It doesn’t heal by itself—scientists transform it through precise reactions, inserting it into experimental molecules. If you peek through scientific publications, you’ll see it pop up in studies on new antiparasitic agents or molecules designed to track down tumors by exploiting the way cancer cells process oxygen. The compound’s nitro group—the bit with nitrogen and oxygen—lets medicinal chemists tweak biological properties, pushing toward molecules that stick to targets in the body that haven’t been hit before.
This compound comes with baggage. Nitroimidazoles have a past: early drugs sometimes led to resistance and side effects. While scientists value the reactivity of the nitro group, they have to keep one eye on safety. Handling nitro compounds means keeping strict lab protocols. One mistake might cause exposure issues or environmental problems. Regulations often require deep paperwork before chemicals like this leave the lab shelf. To people outside of medicinal chemistry, it looks like red tape, but every safety data sheet reflects past accidents and the need to protect both people and the planet.
As bacteria and parasites outsmart standard medicines, research into new types of nitroimidazole-based drugs takes on urgent importance. Antibiotic resistance now challenges hospitals worldwide. Families in every corner of the globe have stories about “medicines that used to work but don’t anymore.” The core chemistry of 2-Methyl-4,5-nitroimidazole helps build new strategies against persistent bugs, cancer, even certain inflammatory diseases. Through structure-activity studies, teams can hunt for molecules with fewer side effects and stronger impact against threats that outpace older options.
Some companies push toward greener processes for synthesizing nitroimidazoles, using fewer hazardous reagents and recycling solvents. Grants and new partnerships back research that harnesses these building blocks for both human and animal medicine. By supporting ethical labs and sharing data about toxicity and environmental fate, scientists aim to keep the benefits rolling out, while shrinking the risks in handling and use.
The story of 2-Methyl-4,5-nitroimidazole points to teamwork between chemists, doctors, safety officers, and regulators. New discoveries require both brains and safeguards. Building on the backbone of small molecules like this, researchers can help future generations fight infections and cancer that still take lives today. As someone who’s spent time hunting for new leads in the lab, I can say these small steps in chemical innovation—measured in grams, milliliters, and hours—have ripple effects that touch the world far beyond the bench.
Working in labs for several years, I’ve seen the effects of getting too comfortable around chemicals. 2-Methyl-4,5-nitroimidazole, a nitroimidazole derivative, brings some risks that can’t be ignored. Its structure tells us a lot: nitro groups often turn up as red flags in chemical safety sheets. Some folks find those flags easy to wave off, but small mistakes with compounds like this can create long-term problems.
I’ve watched colleagues get a rash after not wearing gloves or forgetting goggles during mixing. Skin contact seems harmless until irritation appears within hours. Inhalation risks feel just as real the moment you open a bottle. Organic powders drift in the air and, before you know it, the faint chemical smell signals a leak or poor handling. Even brief contact can cause headaches and breathing trouble; anyone sensitive to irritants shouldn’t ignore these early signs.
Not all labs stock the same gear, but basic protection goes a long way. Nitrile gloves—always my pick over latex for chemical work—reduce the odds of skin exposure. Also, splash-proof goggles never feel optional. Lab coats with closed wrists keep sleeves free from spill-over. I recall spilling a few drops onto my sleeve years ago; quick removal of my coat probably saved my arm from a chemical burn.
If powder transfer lands on your face shield, you’re glad for that extra barrier. Only a fool works with volatile solvents around this imidazole without a fume hood. Negative air pressure and good ventilation won’t just save your lungs; they keep background exposure low for the whole lab team.
I’ve dealt with my share of spills, and ignoring the right steps leads to regret. If 2-Methyl-4,5-nitroimidazole lands on a bench, damp cloths just spread it around. Dry spill control agents trap powder, making it much simpler—and less hazardous—to clean up. I always keep a spill kit close, and I push others to do the same.
Never sweep up dry powder. That puts invisible dust in the air and lands it in your lungs. Only after securing your PPE should clean-up begin. Many labs skimp on this training, and that leaves people exposed to bigger risks than a stained coat.
It’s easy to treat bottles as one-size-fits-all, but not every compound belongs on the same shelf. 2-Methyl-4,5-nitroimidazole needs to stay in tightly sealed, clearly labeled containers, away from heat and open flame. Nitro compounds, even low-level ones, can sometimes decompose and cause trouble if stored near incompatible chemicals, especially reducing agents.
Moving this material requires a plan. Never store unfamiliar compounds until double-checking the safety data sheet. Keeping an up-to-date inventory and clear labeling not only follows regulations but also protects anyone else who steps into the lab.
Standard protocols save a lot of headaches. Wash hands after use, even with gloves. Always keep eating and drinking outside the work area—one forgotten sandwich in a glovebox can spell disaster. Emergency eyewash stations and showers should stay accessible. Regular safety drills help keep everyone on their toes.
Good habits, backed by real training and honest respect for chemicals, guard against the unexpected. Skipping steps or rushing doesn’t just risk a ruined experiment; it puts health and careers in the firing line.
2-Methyl-4,5-nitroimidazole takes on a straightforward imidazole backbone. This five-membered ring features two nitrogen atoms positioned at carbons 1 and 3. A methyl group branches off at the 2-position. Nitro groups anchor themselves at the 4 and 5 positions. Chemists describe its molecular formula as C4H4N4O4. The nitro groups (–NO2) add weight and electron-drawing character, altering the ring’s behavior.
Visualizing the structure makes all the difference. Imagine the imidazole ring as a pentagon: at the top corners sit the two nitrogens, and at the lower right side, the methyl group sprouts upward off position two. Both nitro groups hang off positions 4 and 5, giving the molecule a far more reactive edge than a plain imidazole.
The details matter. Modern medicine, particularly in work against anaerobic bacteria and protozoa, recognizes the value of nitroimidazole compounds. Add a methyl group and two nitro substituents, and the chemical profile shifts. The nitro groups promote reduction under low-oxygen conditions. Pathogens living in such environments trigger this reduction, making the compound active only where needed, reducing collateral damage to healthy cells. This targeted activity builds on decades of work with imidazole drugs.
Lab experience suggests the delicate balance in substitutions. A simple switch in position can affect solubility, permeability, and toxicity. The presence of both methyl and nitro groups at these particular sites nudges the molecule’s pharmacokinetics in useful directions—enough to inspire real-world testing. The addition of these groups has shown to modify the electron density and influence binding interactions with microbial targets. That selective action, rather than blanket toxicity, underscores the potential for next-generation therapeutics that work smarter, not just harder.
On the flip side, synthetic complexity can get tricky. Multiple functional groups packed into a small molecule sometimes bump up the cost and difficulty of production. Inconsistent yields show up during scale-up, as I saw firsthand in graduate labs where nitroimidazoles often demanded careful, staged addition of reagents to avoid runaway side reactions. Optimizing these reactions could involve better catalysis or more selective starting materials.
Another factor is safety. Nitroaromatic groups bring both promise and risk. Metabolites can sometimes be mutagenic or toxic, so early and thorough screening becomes crucial. Developers need clear information about long-term impacts, not just short-term antimicrobial activity. More predictive toxicology assays and a commitment to transparency help keep the risks in check.
Understanding the chemical structure of 2-methyl-4,5-nitroimidazole means more than just memorizing a formula. It opens conversation between chemists, biologists, and pharmacologists. When each detail falls into place—the methyl at position 2, the two nitro groups at positions 4 and 5, the positions of the nitrogens in the ring—science moves ahead with intention. Work on this structure highlights how much potential lies in every small change, especially when exploring new drug design for targeted therapies and resistant infections.
Deep familiarity with these molecules equips researchers and healthcare professionals to push boundaries safely and creatively, guided by a mix of robust evidence, practical experience, and a sharp eye for detail.
2-Methyl-4,5-nitroimidazole packs a potent chemical structure. It gets used in synthesis and research, but its volatility and toxicity mean storage isn’t something you leave to chance. Keeping this chemical stable matters for safety and research accuracy, and also for anybody working nearby, whether that’s a career scientist or a rookie lab assistant.
Every chemist learns pretty quickly that many lab disasters start with a few small missteps. For 2-Methyl-4,5-nitroimidazole, temperature swings make things dicey. Exposure to heat and open flame isn’t just bad practice—it creates risk. This compound can break down or even produce harmful byproducts if mishandled. One lab I worked in had a close call when someone left a similar chemical on a sunny windowsill for a weekend. That lesson sticks: vigilance pays off.
Put this compound in a cool, dry, and well-ventilated area. By “cool,” think controlled room temperature, not just the draftiest cabinet you can find. Humidity turns chemicals unpredictable, and moisture can set off reactions you never planned for. Avoiding direct sunlight keeps the compound’s structure stable. I opt for opaque or amber bottles that block out light, just in case.
Keep containers tightly sealed. The less air gets in, the less chance for oxidation or other unwanted changes. I once learned the hard way that loose lids aren’t just a nuisance; they’re a safety hazard, drawing in moisture and contaminants that slowly mess with your inventory.
Industry guidance steers people toward high-density polyethylene or glass containers—it’s not hype. Softer plastics can leach compounds that interact with 2-Methyl-4,5-nitroimidazole, muddying up experiments or even causing slow reactions in storage.
Don’t put stock chemicals right next to strong acids, bases, or oxidizers. I have seen busy labs cut corners and squish chemicals together on one shelf. The risk isn’t always immediate, but over time, vapors and accidental spills add up. Give sensitive compounds dedicated space, ideally in a locked chemical cabinet designed for hazardous organics. I’ve watched good labs implement color-coded storage and clear labels, making sure no one fumbles around for a vial in a hurry.
Part of storing chemicals safely comes down to tracking stock. Use clear labels with purchase or opening dates. I’ve worked in places with mystery jars, and nobody wins when an old compound goes off because no one remembered how long it’s sat. Modern labs set reminders for periodic inspections, swapping out old stock before it causes headaches.
Labs that value safety keep protocols simple but rigid: dedicated storage, consistent labeling, and regular checks. Invest in secondary containment, like spill trays, to catch leaks before they cause trouble. If budget allows, go for fire-resistant cabinets in line with chemical storage codes. Training isn’t a burden—it’s an expectation. Make sure everyone in the space knows not just where 2-Methyl-4,5-nitroimidazole sits, but how to handle it if trouble brews. Safety builds trust and keeps people coming home at the end of the day.
Rolling through catalogues of chemical suppliers brings up a simple question: Can you actually buy 2-Methyl-4,5-nitroimidazole for lab or industrial applications? On paper, there’s always talk about research chemicals expanding the scientific edge, but a compound like this often lands in something of a grey area.
Ask any researcher who’s tried to order something a bit off the mainstream path. The more niche or sensitive a chemical, the more hoops appear in the ordering process. For 2-Methyl-4,5-nitroimidazole, catalog hits remain sparse—big suppliers don’t list it, smaller companies might only acknowledge a custom synthesis. Availability always comes down to regulatory scrutiny and the backstory of the molecule. Sometimes, new uses, especially in pharmaceuticals or diagnostics, bring old compounds into demand. With this one, a casual internet search yields patchy results at best, and reliable stock, even less so.
Governments keep close tabs on compounds that could double as precursors for more hazardous chemicals or fit the profile of controlled substances. Taking shortcuts here risks a ton of trouble. My colleagues in chemical supply say the mounting paperwork on nitroimidazole derivatives drives up costs and headaches, stalling launches. Historically, imidazole chemistry links to antimicrobial and antiprotozoal uses, but once derivatives cross into territory flagged by regulatory lists, manufacturers step back. One regulatory database after another carries those warnings: pay attention, check end uses, clear your paperwork.
Despite all the bottlenecks, researchers want these materials. Specialty chemistry often sits behind breakthroughs, from drug screens to complex sensor tech. A scientist in diagnostics shared that missing just one derivative can waste months, forcing pivots back to less direct approaches. That one inaccessible molecule can hold up a multi-million-dollar study or medical project. Lab procurement officers face a constant dance between chasing rare reagents and keeping compliance airtight. Chalk it up to real-world research life—the frustration of filling out customs forms, background forms, safety sheets, and still hearing “item not available.”
Fixing the chokepoint takes real communication between regulators, suppliers, and end users. This doesn’t mean shoving safety out the door. Most chemists want transparency, fair access, and some creativity from suppliers. Trusted companies already carry high-risk molecules under stricter Know Your Customer policies. The same systems could work for more hard-to-get imidazoles with clear paperwork, solid tracking, and educated clients. Scientists benefit from supplier partnerships that teach responsible use and flag suspicious orders without hobbling genuine research. Open channels get researchers what they need, keep communities safer, and support work that saves lives down the road.
It’s on every part of the supply chain to watch out for red flags, but it’s also on companies and regulators not to punish everyone for the few who break the rules. Universities, pharmaceutical companies, and start-ups all lose when a shortage of specialty chemicals halts progress. Hard conversations around supply and compliance keep trust strong—shared responsibility keeps science ethical, and keeps the best tools in the hands of responsible teams. The more we keep things above board, the smoother the path for everyone who relies on molecules that drive research forward.
| Names | |
| Preferred IUPAC name | 2-methyl-4,5-dinitro-1H-imidazole |
| Other names |
2-Methyl-4,5-dinitroimidazole 2-Methylimidazole-4,5-dinitro 4,5-Dinitro-2-methylimidazole |
| Pronunciation | /tuː ˈmɛθ.ɪl ˌfɔːr ˈfaɪv ˈnaɪ.trəʊ ɪˈmɪd.əˌzəʊl/ |
| Identifiers | |
| CAS Number | 3554-77-2 |
| Beilstein Reference | 101184 |
| ChEBI | CHEBI:75018 |
| ChEMBL | CHEMBL270907 |
| ChemSpider | 66140 |
| DrugBank | DB02374 |
| ECHA InfoCard | 03a6bfa2-dc9c-4202-91de-75940844aed7 |
| EC Number | 697-395-6 |
| Gmelin Reference | 82216 |
| KEGG | C14318 |
| MeSH | D008768 |
| PubChem CID | 39846 |
| RTECS number | NR3675000 |
| UNII | 229T3746T4 |
| UN number | Not regulated |
| Properties | |
| Chemical formula | C4H5N3O2 |
| Molar mass | Molar mass: 141.11 g/mol |
| Appearance | Light yellow powder |
| Odor | Odorless |
| Density | 1.36 g/cm³ |
| Solubility in water | soluble |
| log P | 0.02 |
| Vapor pressure | 1.5E-4 mmHg at 25 °C |
| Acidity (pKa) | 7.18 |
| Basicity (pKb) | 11.02 |
| Magnetic susceptibility (χ) | -48.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.539 |
| Dipole moment | 3.73 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 190.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | −73.7 kJ mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -1515 kJ/mol |
| Pharmacology | |
| ATC code | J01XD03 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes serious eye irritation |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P305+P351+P338, P308+P311, P330, P501 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 1, Special: '' |
| Flash point | 100 °C |
| Lethal dose or concentration | LD50 oral rat 960 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral rat LD50 1050 mg/kg |
| NIOSH | ST2500000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.05 mg/m³ |
| Related compounds | |
| Related compounds |
Imidazole 2-Methylimidazole 4,5-Dinitroimidazole 4-Nitroimidazole 5-Nitroimidazole |
